Y Aymé

2.7k total citations
34 papers, 2.1k citations indexed

About

Y Aymé is a scholar working on Cancer Research, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Y Aymé has authored 34 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Cancer Research, 15 papers in Pathology and Forensic Medicine and 14 papers in Oncology. Recurrent topics in Y Aymé's work include Breast Cancer Treatment Studies (26 papers), Breast Lesions and Carcinomas (12 papers) and Cancer Treatment and Pharmacology (4 papers). Y Aymé is often cited by papers focused on Breast Cancer Treatment Studies (26 papers), Breast Lesions and Carcinomas (12 papers) and Cancer Treatment and Pharmacology (4 papers). Y Aymé collaborates with scholars based in France, Switzerland and United States. Y Aymé's co-authors include H Brandone, J M Spitalier, R. Amalric, Daniel Hans, C Bressac, John M. Kurtz, Jocelyne Jacquemier, R Amalric, Jocelyne Jacquemier and Julia Kurtz and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Surgery.

In The Last Decade

Y Aymé

33 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Y Aymé France	19	1.8k	1.3k	840	612	249	34	2.1k
H Brandone France	19	1.9k 1.0×	1.3k 1.0×	851 1.0×	588 1.0×	259 1.0×	33	2.1k
R. Amalric France	17	1.8k 1.0×	1.3k 1.0×	831 1.0×	503 0.8×	249 1.0×	38	2.1k
J M Spitalier France	17	1.7k 0.9×	1.2k 0.9×	761 0.9×	511 0.8×	230 0.9×	24	1.9k
S J Schnitt United States	17	1.6k 0.9×	1.1k 0.9×	816 1.0×	445 0.7×	322 1.3×	33	2.1k
J.C. Durand France	18	1.5k 0.8×	1.1k 0.8×	972 1.2×	548 0.9×	216 0.9×	30	2.2k
Jeffrey R. Harris United States	13	1.0k 0.5×	717 0.6×	523 0.6×	332 0.5×	156 0.6×	23	1.3k
Sharon Galper United States	8	1.4k 0.8×	1.1k 0.8×	562 0.7×	729 1.2×	81 0.3×	8	1.7k
J.R. Vilcoq France	13	1.1k 0.6×	668 0.5×	720 0.9×	297 0.5×	176 0.7×	22	1.4k
Parvis Gamagami Switzerland	19	2.3k 1.2×	1.9k 1.4×	875 1.0×	917 1.5×	167 0.7×	31	2.7k
Jacques R. Vilcoq France	13	936 0.5×	661 0.5×	520 0.6×	252 0.4×	114 0.5×	14	1.3k

Countries citing papers authored by Y Aymé

Since Specialization

Citations

This map shows the geographic impact of Y Aymé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y Aymé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y Aymé more than expected).

Fields of papers citing papers by Y Aymé

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y Aymé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y Aymé. The network helps show where Y Aymé may publish in the future.

Co-authorship network of co-authors of Y Aymé

This figure shows the co-authorship network connecting the top 25 collaborators of Y Aymé. A scholar is included among the top collaborators of Y Aymé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y Aymé. Y Aymé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Aymé, Y, R. Amalric, Julia Kurtz, & J M Spitalier. (1993). Long‐Term Results of Conservation Treatment of Operable Breast Cancer. Annals of the New York Academy of Sciences. 698(1). 259–263. 1 indexed citations

Viens, Patrice, Didier Blaise, A.-M. Stoppa, et al.. (1992). Interleukin-2 in Association with Increasing Doses of Interferon-Gamma in Patients with Advanced Cancer. Journal of Immunotherapy. 11(3). 218–224. 3 indexed citations

Kurtz, John M., Jocelyne Jacquemier, R Amalric, et al.. (1991). Is breast conservation after local recurrence feasible?. European Journal of Cancer and Clinical Oncology. 27(3). 240–244. 86 indexed citations

Kurtz, John M., R. Amalric, H Brandone, Y Aymé, & J M Spitalier. (1991). How important is adequate radiotherapy for the long-term results of breast-conserving treatment?. Radiotherapy and Oncology. 20(2). 84–90. 18 indexed citations

Kurtz, Julia, Jocelyne Jacquemier, R. Amalric, et al.. (1990). Why are local recurrences after breast-conserving therapy more frequent in younger patients?. Journal of Clinical Oncology. 8(4). 591–598. 205 indexed citations

Kurtz, John M., J M Spitalier, R. Amalric, et al.. (1990). The prognostic significance of late local recurrence after breast-conserving therapy. International Journal of Radiation Oncology*Biology*Physics. 18(1). 87–93. 145 indexed citations

Kurtz, John M., Jocelyne Jacquemier, R. Amalric, et al.. (1990). Risk factors for breast recurrence in premenopausal and postmenopausal patients with ductal cancers treated by conservation therapy. Cancer. 65(8). 1867–1878. 157 indexed citations

Jacquemier, Jocelyne, et al.. (1990). Breast-conserving Therapy for Macroscopically Multiple Cancers. Annals of Surgery. 212(1). 38–44. 156 indexed citations

Jacquemier, Jocelyne, et al.. (1990). An assessment of extensive intraductal component as a risk factor for local recurrence after breast-conserving therapy. British Journal of Cancer. 61(6). 873–876. 84 indexed citations

10.

Chauvergne, J, Jean‐François Héron, Y Aymé, et al.. (1990). [Randomized trial of initial chemotherapy in 151 locally advanced carcinoma of the cervix (T2b-N1, T3b, MO)].. PubMed. 77(10). 1007–24. 19 indexed citations

11.

Kurtz, John M., R. Amalric, H Brandone, et al.. (1989). Local recurrence after breast-conserving surgery and radiotherapy. Frequency, time course, and prognosis. Cancer. 63(10). 1912–1917. 341 indexed citations

12.

Jacquemier, J, et al.. (1989). [Clinically impalpable mammary carcinoma: morphologic and histogenetic analysis. Apropos of 114 cases].. PubMed. 76(6). 653–63. 1 indexed citations

13.

Kurtz, John M., Jocelyne Jacquemier, J. Torhorst, et al.. (1989). Conservation therapy for breast cancers other than infiltrating ductal carcinoma. Cancer. 63(8). 1630–1635. 154 indexed citations

14.

Amalric, R, et al.. (1989). Local recurrence after breast-conserving surgery and radiotherapy.. PubMed. 55(6). 837–42. 144 indexed citations

15.

Kurtz, John M., R. Amalric, H Brandone, Y Aymé, & J M Spitalier. (1988). Contralateral breast cancer and other second malignancies in patients treated by breast-conserving therapy with radiation. International Journal of Radiation Oncology*Biology*Physics. 15(2). 277–284. 81 indexed citations

16.

Kurtz, John M., R Amalric, H Brandone, Y Aymé, & J M Spitalier. (1988). Results of wide excision for mammary recurrence after breast-conserving therapy. Cancer. 61(10). 1969–1972. 68 indexed citations

17.

Kurtz, John M., J M Spitalier, R. Amalric, et al.. (1988). Mammary recurrences in women younger than forty. International Journal of Radiation Oncology*Biology*Physics. 15(2). 271–276. 102 indexed citations

18.

Amalric, R., et al.. (1984). Radiation therapy after breast-conserving surgery for Stage I and II mammary carcinoma. Results of the Marseille experience 1961 to 1976.. PubMed. 160(4). 239–43. 3 indexed citations

19.

Brandone, H, et al.. (1978). [Curative conservative treatment of benign operable breast cancers (705 cases with a 5-year follow-up)].. PubMed. 44(5-6). 629–38. 1 indexed citations

20.

Aymé, Y, et al.. (1976). Radiothérapie curative à espérance conservatrice des cancers du sein opérables. 403 cas de 5 ans. Bulletin du Cancer. 63(2). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact